Industry Focus

Healthcare: Are Biotech Stocks Really Overvalued?


Listen Later

Biotech stocks eye-popping run has investors nervous of a bubble. Healthcare Fool's Michael Douglass and Todd Campbell weigh in with their take on biotech valuation.

...more
View all episodesView all episodes
Download on the App Store

Industry FocusBy The Motley Fool